Conferences Karyopharm Therapeutics is attending in 2026–2027
Karyopharm Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026–2027: ASH 2026 (exhibiting) and ASCO 2027 (exhibiting). Karyopharm Therapeutics is an oncology drug developer focused on treatments that inhibit nuclear export, including selinexor for blood cancers. As of Oct 20, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site |
New Orleans, LA ~30k attendees | ExhibitorAs published by American Society of Hematology Booth 939Program 1 symposium
|
Open the guide Search and filter attendees |
ASCO Annual Meeting 2027World’s largest clinical oncology meetingOfficial site |
Chicago, IL ~44k attendees | ExhibitorAs published by American Society of Clinical Oncology Booth 30155
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Karyopharm Therapeutics’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Karyopharm Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!